A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection

ID Number 12-0534

Principal Investigator(s)
Ponni Perumalswami

Department(s) or Division(s)
Liver Diseases

Description

The purpose of this study is to continue to evaluate the subjects HCV infection after they have completed participation in a Gilead-sponsored treatment study for hepatitis C. Subjects may qualify to take part in this research study, because they have previously participated in a Gilead-sponsored study for treating chronic hepatitis C (HCV) infection. During their participation in the treatment study the hepatitis C virus was still found in their blood.

This study is a long term follow-up to continue to evaluate their HCV infection. No study medication will be administered. Their participation in this research study is expected to last up to 3 years. The number of people expected to take part in this research study at this site is 10.



Contact Information
Shanti Mangar
(212) 241-0493
shanti.mangar@mssm.edu

Recruiting Patients: No